Application of Machine Learning for Predicting Progression‐Free and Overall Survival in Patients With Renal Cell Carcinoma
Caroline W. Grant, Jerry Li, Swan Lin, Dana Nickens et al. • Clinical and Translational Science
(2025)
ABSTRACT Patient outcomes in advanced renal cell carcinoma (RCC) remain poor, with five‐year survival rates ranging from ~10% to 30%. Early projections of therapeutic outcomes could optimize precision medicine and accelerate drug developmen...
DOAJ
Open Access (DOAJ)
DOI:
10.1111/cts.70348